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Introduction
The frequent collection of blood specimens in the intensive care
unit (ICU) may contribute to iatrogenic blood loss [1,2], com-
pounding the problem of acute anemia that is frequently found
among individuals with active hemorrhage, with a bleeding
diathesis or with hemodilutional anemia [3]. The lag time in the
diagnosis of severe acute anemia, due to long laboratory turn-
around times, may have important clinical consequence [2,4,5].
The availability of arterial blood gas (ABG) analyzers in most
ICUs and hospital laboratories enables rapid analysis of not only
traditional blood gas elements, such as pH and pO2, but also
Hb concentration. Because little is known about the accuracy of
ABG analysis for the determination of Hb concentration, we
prospectively evaluated its use in a critical care setting.
Methods
This study was conducted at the Hamilton General Hospital,
a 32-bed medical and surgical ICU covering treatment that
ABG = arterial blood gas; CI = confidence interval; Hb = hemoglobin; ICU = intensive care unit.
Abstract
Objective To evaluate whether measurement of the hemoglobin (Hb) concentration with a blood gas
analyzer approximates that determined by a conventional coulter counter in critically ill adults.
Design Prospective patient series.
Setting A 32-bed cardiovascular, neurosurgical, trauma and medical–surgical intensive care unit in a
single Canadian center.
Patients We consecutively recruited 202 critically ill adults, the majority of whom had recent cardiac or
vascular surgery, neurosurgery or trauma.
Measurements The nurse obtained a single arterial blood sample within a few hours of the patient’s
admission to the intensive care unit. The Hb concentration was determined from each blood sample in
a masked fashion, using both a blood gas analyzer and a conventional laboratory coulter counter.
Main results A total of 202 consecutive paired analyses were conducted. There was a highly significant
correlation between the coulter counter and blood gas analyzer methods of Hb measurement (r2 = 0.98,
95% confidence interval [CI] = 0.97–0.99; P < 0.0001). Using the method of Bland and Altman, the
overall mean difference in Hb concentration between the coulter counter and the blood gas analyzer
was –4.3 g/l (95% CI = –11.0 to 2.4). Of the 11 (5.4%) Hb measurements that extended beyond the
upper and lower 95% CI, 10 (5.0%) were within ±3 g/l of these confidence limits.
Conclusions An arterial blood gas analyzer may provide a valid alternative method to the traditional
coulter counter for the rapid assessment of Hb concentration among critically ill adults. Since issues
related to its safety, quality control, data entry and cost savings have yet to be addressed, however,
use of such point of care testing should be viewed as a supplement to conventional laboratory testing.
Keywords arterial blood gas, coulter counter, critical care, hemoglobin concentration, intensive care unit
Received: 5 October 2001
Accepted: 24 October 2001
Published: 19 November 2001
Critical Care 2002, 6:72-75
© 2002 Ray et al., licensee BioMed Central Ltd
(Print ISSN 1364-8535; Online ISSN 1466-609X)Available online http://ccforum.com/content/6/1/072
includes trauma, neurosurgical and cardiovascular sub-
specialty care. All consecutive patients admitted to the ICU
during the period between 18 June and 16 July 2000 were
included. As part of their routine admitting bloodwork, an
arterial whole blood specimen was obtained from each
patient by his/her ICU nurse, shortly after admission to the
ICU. A portion of that specimen was placed directly into a
heparinized ABG gas syringe, while the remainder was
placed in an EDTA vacuum collection tube. The ABG syringe
was transported on ice to the hospital core laboratory and
analyzed using a calibrated Chiron 855 ABG analyzer (Chiron
Diagnostics, Medfield, MA, USA). The EDTA blood specimen
tube was transported at room temperature to the same core
laboratory, where a calibrated Beckman Coulter Gen-S
coulter counter (Beckman Coulter Corporation, Kendal, FL,
USA) was used to measure the Hb concentration. Process-
ing of the ABG and coulter counter specimens was carried
out by different laboratory technologists, who were masked to
each other’s test results. The Chiron 855 ABG analyzer
determines the Hb concentration using a spectrophotometric
carbon monoxide oximeter module, and has a within-run pre-
cision of ±3 g/l and an accuracy within ±3 g/l [6]. The
Beckman Coulter Gen-S system has a within-run precision of
±1.2 g/l and an accuracy within ±2 g/l [7].
All data were entered into the hospital’s patient care com-
puter. These data were subsequently abstracted by one
author and entered into an Excel 5.0 file (1994 Microsoft
Corporation). The mean coulter counter and ABG Hb values
were compared using an unpaired t test. We also calculated
the square of the Pearson correlation coefficient (r2) for the
Hb concentration measured by the ABG analyzer versus that
measured by the coulter counter. We then applied the
method of Bland and Altman to plot the average of each
coulter counter and ABG Hb pair against the coulter
counter – ABG Hb difference for that same pair [8]. The r2
value was also calculated for the relationship between the
average Hb concentration and the coulter counter – ABG Hb
difference. All data are presented with a 95% CI, and statisti-
cal significance was set at a two-sided P value of 0.05. The
Hamilton Health Sciences Corporation Research Ethics
Board granted permission to conduct this study.
Results
A total of 202 patients were included in this study. The mean
age was 64.1 years, 65% were male, and the initial mean
Acute Physiology and Chronic Health Evaluation II score was
20.0 (Table 1). More than one-half of the participants had
undergone cardiac surgery, while most of the remaining
patients had experienced neurosurgery, vascular surgery or
major trauma.
The mean Hb concentration measured by the coulter counter
was 102.9 g/l (standard deviation = 22.7 g/l), while that mea-
sured by the ABG was 107.2 g/l (standard devia-
tion = 23.2 g/l) (mean difference = 4.3 g/l; P = 0.060). There
was a strong and highly significant positive correlation
between the coulter counter and the ABG methods of Hb
determination (r2 = 0.98, 95% CI = 0.97–0.99; P < 0.0001)
(Fig. 1).
Figure 2 presents the average Hb concentration plotted
against the corresponding coulter counter – ABG Hb differ-
ence [8]. The overall mean coulter counter – ABG Hb differ-
ence was –4.3 g/l, with lower and upper 95% CI limits of
–11.0 and 2.4 g/l, respectively. A total of 11 measurements
(5.4%) extended beyond the upper or lower 95% CI limit
(Fig. 2). Of the six points that were beyond the upper 95% CI
limit, all remained within 3 g/l above that limit; of the five mea-
surements extending below the lower 95% CI limit, however,
only one was more than 3 g/l beyond that limit (Fig. 2). There
was a weakly significant relationship between the mean Hb
and the coulter counter – ABG Hb difference (r2 = 0.03, 95%
CI = 0.001–0.10;  P = 0.02), suggesting a minimal trend in
the coulter counter – ABG Hb difference with a rising Hb
concentration.
Discussion
We compared the use of an ABG analyzer with the use of a
traditional coulter counter for the evaluation of the Hb con-
centration among 202 critically ill adults. We observed that
the ABG analyzer provides a reasonable estimate of the Hb
concentration over a broad array of values, but typically over-
estimates the Hb value by approximately 4.3 g/l.
One limitation to the current study is that we did not define
which patients were actively bleeding, or which had received
a red cell transfusion or colloid or crystalloid infusions. It is
very probable that all study participants had received some
quantity of intravenous fluids, while many had probably
received either autologous or donor red cells at the time of
their surgery. Since the coulter counter and ABG specimens
were collected at the same time, dynamic fluid or whole
blood shifts should not have biased our results. The average
Hb concentration observed herein was 105 g/l, ranging from
as low as 59.5 g/l to as high as 225 g/l (Fig. 2). Since there
was little evidence of a systematic trend in the number of out-
liers at either Hb extreme, ABG analysis appears to provide a
consistent approximation of the Hb concentration for most
Hb values seen within the ICU setting.
New and simpler methods for point of care testing have
evolved to the extent that they appear to be highly accurate
within the critical care setting [2,9]. In a study comparing
point of care testing, using an on-site hemocytometer, with a
laboratory coulter counter among 187 cardiac surgical ICU
patients, the r2 value for the measured Hb concentration was
0.97 [10]. We also observed a strong correlation (r2 = 0.98)
between the two methods assessed herein, and found that
fewer than 6% of the coulter counter – ABG differences were
beyond the average value of –4.3 g/l and its lower and upper
95% CI limits of –11.0 and 2.4 g/l, respectively. Furthermore,Critical Care    February 2001 Vol 6 No 1 Ray et al.
only one of these 11 points surpassed the 95% confidence
limits by more than 3 g/l.
It is reasonable to conclude that direct measurement of Hb
concentration using an ABG analyzer may provide a valid
alternative method to a traditional coulter counter. In only the
rarest situation is a precise estimate of the Hb concentration
necessary in caring for the critically ill patient [11]. Since the
ABG analyzer appears to overestimate the ‘true’ Hb concen-
tration by 4.3 g/l, on average, there remains a margin of safety
that would neither place a patient in a state of unrecognized
life-threatening anemia, nor lead to an unnecessary red cell
transfusion. In a recently conducted, randomized clinical trial
Table 1
Characteristics of 202 critically ill adults who underwent concomitant determinations of arterial blood gas and coulter counter
hemoglobin concentrations
Characteristic Measurement
Number (%) of males 132 (65.3)
Mean (SD) age (years) 64.1 (15.5)
Mean (SD) APACHE II score 20.0 (6.7)
Number (%) of patients admitted to the ICU according to specialty service
Cardiac surgery 103 (51.0)
Neurosurgery 37 (18.3)
Vascular surgery 24 (11.9)
Trauma 12 (5.9)
Medicine 11 (5.4)
Other 15 (7.4)
Total 202 (100.0)
Mean (SD) length of stay in the ICU (days) 3.4 (4.6)
Number (%) of patients deceased at completion of data collection 28 (13.9)
Mean (SD) hemoglobin concentration shortly after admission to the ICU (g/l)
Coulter counter 102.9 (22.7)
Arterial blood gas analyzer 107.2 (23.2)
Average of both methods 105.0 (22.9)
APACHE II, Acute Physiology and Chronic Health Evaluation II; ICU, intensive care unit; SD, standard deviation.
Figure 2
Average hemoglobin concentration versus the coulter counter – arterial
blood gas (ABG) hemoglobin difference among 202 critically ill adults.
CI, confidence interval.
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Figure 1
Hemoglobin concentration measured by coulter counter (CC) versus
an arterial blood gas analyzer (ABG) among 202 critically ill adults.
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)of 357 critically ill patients with cardiovascular disease, those
who were maintained at a Hb concentration between 70 and
90 g/l had no difference in 30-day or 60-day mortality rates
compared with those patients whose Hb was maintained
between 100 and 120 g/l [11]. Within facilities where the
ABG analyzer is available, it is thus reasonable for each facil-
ity to assess the accuracy of its own ABG analyzer relative to
its current laboratory method of Hb determination. By per-
forming fewer complete blood counts there may be less iatro-
genic blood loss, a faster therapeutic turnaround time and,
perhaps, some cost savings [9].
Since we determined the ABG Hb concentration within a
hospital core laboratory, our findings do not necessarily apply
to the situation of true point of care testing; nonetheless,
many ICUs have been equipped with their own ABG analyz-
ers for several years [12]. Point of care testing may become
the standard of practice [9], but there is a further need for
research on its utility within the ICU [2]. If testing is not
handled by the main hospital laboratory, both central com-
puter data entry and quality control may be sacrificed. A
large, simple, multicenter, prospective study might optimally
address the safety and cost savings of ABG Hb analysis in
the ICU. In the mean time, use of point of care tests in the
ICU, such as the ABG Hb determination, should be not be
viewed as a replacement for conventional laboratory services,
but as a supplement [2].
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